Folotyn Solution For Injection 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Folotyn: Solution for injection (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PRALATREXATE (pral a TREX ate) is a chemotherapy drug. This medicine affects cells that are rapidly growing, such as cancer cells. It is used to treat lymphoma, a certain type of cancer.

In-Depth Information

Folotyn 20mg/ml Solution for Injection

NDC: 488180001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Peripheral T-cell Lymphoma (PTCL), Non-Hodgkin's Lymphoma (NHL)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
Folotyn 20mg/ml Solution for Injection

Reported Side Effects for Folotyn 20mg/ml Solution for Injection

Skin Ulcer Incidence:
<2.1%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<2.1%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Itching Incidence:
2.0%*
Severity: SEVERE
Onset: RAPID
Dehydration Incidence:
>3.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Stomach Pain Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Low Potassium Levels Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
7.0%*
Severity: SEVERE
Onset: EARLY
Shortness Of Breath Incidence:
7.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
10.0%*
Severity: MODERATE
Onset: RAPID
Night Sweats Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
17.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
20.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
21.0%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
26.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
33.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
33.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Folotyn

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5